Loading...
Loading...
UTRS| Name | Value |
|---|---|
| Revenues | 12.0M |
| Cost of Revenue | 5.7M |
| Gross Profit | 6.2M |
| Operating Expense | 12.3M |
| Operating I/L | -6.1M |
| Other Income/Expense | -1.1M |
| Interest Income | 0.1M |
| Pretax | -7.2M |
| Income Tax Expense | -0.0M |
| Net Income/Loss | -7.2M |
Minerva Surgical, Inc. is a medical technology company specializing in minimally invasive solutions for uterine healthcare. Their products include the Minerva ES and Genesys HTA Endometrial Ablation Systems for endometrial ablation, the Symphion Tissue Removal System for uterine tissue removal, and the Resectr Tissue Resection Device for hysteroscopic removal of endometrial polyps. These devices are used by obstetrician-gynecologists in hospitals, ambulatory surgical centers, and physician offices, generating revenue through the sale of medical devices and related consumables.
